Mobile Menu

Genomics week in brief: Week ending 4th September

Get your weekly dose of genomics with the latest Genomics Week in Brief, jam-packed with some of the latest genomics news and research from the past week.

Top stories from the past week

  • Researchers have developed a blood test that can reveal when benign tumours turn cancerous in patients with neurofibromatosis type 1. (Szymanski et al, 2021)
  • Scientists have deciphered the genetic mechanisms that are governing the speed of translation of messenger RNA. (Allen et al, 2021)
  • New research has demonstrated that genes are capable of identifying and responding to coded information in light signals. (Lee et al, 2021)
  • Researchers have discovered that aneuploidy is able to drive gain-of-function phenotypes in cells expressing mutant p53. (Redman-Rivera et al, 2021)
  • A new study has demonstrated that a naturally occurring RNA, RN7SL1, can activate the body’s T cells to seek out cancer cells that have escaped recognition by CAR T cells. (Johnson et al, 2021)
  • Scientists have identified a new growth factor produced by blood vessels that enables tumour cells to metastasise. (Singhal et al, 2021)
  • A deep learning tool has been found to offer rapid genetic screening that could accelerate the diagnosis of genetic syndromes in children with diverse backgrounds. (Porras et al, 2021)
  • A team of researchers has identified a novel mechanism by which loss-of-function mutations in the PTPN2 gene in patients with inflammatory bowel disease affects gut leakiness. (Marchelletta et al, 2021)

In other news

  • The Chan Zuckerberg Initiative (CZI) has awarded $33 million in grants to support international groups of researchers and paediatricians to better understand, prevent and treat childhood diseases. The groups will develop single-cell reference datasets that will contribute to the Human Cell Atlas. (Chan Zuckerberg Initiative, 2021)

Image credit – canva

More on these topics

Genetic Variants / Genomics / Week in brief